Video-Assisted Thoracoscopic Lobectomy: State of the Art and Future Directions

Shaw, Jason A.; Dembitzer, Francine R.; Wisnivesky, Juan P.; Litle, Virginia R.; Weiser, Todd S.; Yun, Jaime; Chin, Cynthia; Swanson, Scott J.

doi:10.1016/j.athoracsur.2007.11.048

Cited by 101 publications

(65 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a randomized trial conducted in Germany, there were fewer complications after the VATS approach (14.2%) compared with thoracotomy (50%) [15]. Reported morbidity after VATS pulmonary resections ranges from 7.7% to 29.9% [2,[16][17][18]. The complication rate in this series was 18%, which compares favorably with reported results from conventional VATS approaches.…”

Section: Discussionsupporting

confidence: 85%

A hybrid technique: video-assisted thoracoscopic surgery (VATS) pulmonary resections for community-based surgeons

2009

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 85%

A hybrid technique: video-assisted thoracoscopic surgery (VATS) pulmonary resections for community-based surgeons

2009

View full text Add to dashboard Cite

show abstract

“…However, VATS lobectomy for lung cancer was met with much initial skepticism due to the oncologic concern. With more and more studies proven, VATS lobectomy is now considered to provide a minimally invasive alternative to thoracotomy for early stage lung cancer [8][9][10][11].…”

Section: Introductionmentioning

confidence: 99%

Lobectomy by video-assisted thoracoscopic surgery (VATS) for early stage of non-small cell lung cancer

Zhu

Chen

2011

Front. Med.

View full text Add to dashboard Cite

Video-assisted thoracoscopic surgery (VATS) provides a new approach for treating early-stage lung cancer. Lobectomy by VATS has many advantages over conventional thoracotomy, such as shorter recovery time, less postoperative pain, and faster resumption of a normal lifestyle. However, there is still much debate on the role of VATS in lobectomy for the treatment of lung cancer. Concerns regarding safety, the extent of mediastinal lymph node dissection, and long-term survival have made some surgeons apprehensive of its validity for lung cancer. In this paper, we review the development of thoracoscopy, the present status of VATS for early stage of non-small cell lung cancer (NSCLC), and comparison between VATS and open thoracotomy in the management of NSCLC.

show abstract

“…82,83 Published studies suggest that VATS has several advantages over standard thoracotomy (or pleurotomy). [84][85][86][87][88] Acute and chronic pain associated with VATS is minimal; thus, this procedure requires shorter length of hospitalization. 89 VATS is also associated with low postoperative morbidity and mortality, minimal risk for intraoperative bleeding, and minimal locoregional recurrence.…”

Section: Surgerymentioning

confidence: 99%